Free Trial
NASDAQ:GOSS

Gossamer Bio (GOSS) Stock Price, News & Analysis

Gossamer Bio logo
$1.84 -0.04 (-1.87%)
As of 12:44 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Gossamer Bio Stock (NASDAQ:GOSS)

Key Stats

Today's Range
$1.82
$1.91
50-Day Range
$1.04
$1.87
52-Week Range
$0.66
$1.94
Volume
1.55 million shs
Average Volume
1.79 million shs
Market Capitalization
$417.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.25
Consensus Rating
Buy

Company Overview

Gossamer Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
71st Percentile Overall Score

GOSS MarketRank™: 

Gossamer Bio scored higher than 71% of companies evaluated by MarketBeat, and ranked 287th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Gossamer Bio has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Gossamer Bio has only been the subject of 3 research reports in the past 90 days.

  • Read more about Gossamer Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Gossamer Bio are expected to decrease in the coming year, from ($0.28) to ($0.70) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Gossamer Bio is -8.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Gossamer Bio is -8.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Gossamer Bio has a P/B Ratio of 14.12. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Gossamer Bio's valuation and earnings.
  • Percentage of Shares Shorted

    7.97% of the float of Gossamer Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Gossamer Bio has a short interest ratio ("days to cover") of 9.
  • Change versus previous month

    Short interest in Gossamer Bio has recently increased by 52.62%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Gossamer Bio does not currently pay a dividend.

  • Dividend Growth

    Gossamer Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.97% of the float of Gossamer Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Gossamer Bio has a short interest ratio ("days to cover") of 9.
  • Change versus previous month

    Short interest in Gossamer Bio has recently increased by 52.62%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    13 people have searched for GOSS on MarketBeat in the last 30 days. This is an increase of 63% compared to the previous 30 days.
  • MarketBeat Follows

    7 people have added Gossamer Bio to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Gossamer Bio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.70% of the stock of Gossamer Bio is held by insiders.

  • Percentage Held by Institutions

    81.23% of the stock of Gossamer Bio is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Gossamer Bio's insider trading history.
Receive GOSS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gossamer Bio and its competitors with MarketBeat's FREE daily newsletter.

GOSS Stock News Headlines

Gossamer Bio (NASDAQ:GOSS) Coverage Initiated at Scotiabank
Why Elon put $51 million into this
A single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re quietly shipping 30 tons per year from a facility outside San Antonio.
See More Headlines

GOSS Stock Analysis - Frequently Asked Questions

Gossamer Bio's stock was trading at $0.9046 at the beginning of the year. Since then, GOSS shares have increased by 102.9% and is now trading at $1.8350.

Gossamer Bio, Inc. (NASDAQ:GOSS) released its earnings results on Thursday, May, 15th. The company reported ($0.16) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.02. The company had revenue of $9.89 million for the quarter, compared to analysts' expectations of $3.95 million. Gossamer Bio had a negative net margin of 41.12% and a negative trailing twelve-month return on equity of 128.98%.
Read the conference call transcript
.

Gossamer Bio (GOSS) raised $230 million in an initial public offering on Friday, February 8th 2019. The company issued 14,400,000 shares at a price of $16.00 per share. BofA Merrill Lynch, Leerink Partners, Barclays and Evercore ISI served as the underwriters for the IPO.

Top institutional investors of Gossamer Bio include Platinum Investment Management Ltd. (0.61%). Insiders that own company stock include Faheem Hasnain, Richard Aranda, Bryan Giraudo, Laura Carter and Caryn Peterson.
View institutional ownership trends
.

Shares of GOSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Gossamer Bio investors own include Voyager Therapeutics (VYGR), Waste Connections (WCN), American Water Works (AWK), DiamondRock Hospitality (DRH), The RMR Group (RMR), AU Optronics (AUOTY) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
5/15/2025
Today
7/23/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GOSS
CIK
1728117
Fax
N/A
Employees
180
Year Founded
N/A

Price Target and Rating

High Price Target
$11.00
Low Price Target
$4.00
Potential Upside/Downside
+341.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$56.53 million
Net Margins
-41.12%
Pretax Margin
-40.41%
Return on Equity
-128.98%
Return on Assets
-15.52%

Debt

Debt-to-Equity Ratio
6.70
Current Ratio
5.71
Quick Ratio
5.71

Sales & Book Value

Annual Sales
$114.70 million
Price / Sales
3.71
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.13 per share
Price / Book
14.38

Miscellaneous

Outstanding Shares
227,300,000
Free Float
212,073,000
Market Cap
$425.05 million
Optionable
Optionable
Beta
1.86
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:GOSS) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners